Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Fulcrum Therapeutics
AddedFeb 19, 2024
UpdatedJun 18, 2026
Fulcrum Therapeutics

Fulcrum Therapeutics

Public

Fulcrum Therapeutics, Inc., a Cambridge-based company, develops and distributes transformative gene regulation drugs.

HQ
Cambridge, MA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Fulcrum Therapeutics, Inc., founded in Cambridge, Massachusetts, is dedicated to developing and distributing transformative gene regulation drugs. The company's core mission is to modulate gene expression to treat the root cause of genetically defined diseases, particularly in areas with high unmet medical needs. Fulcrum's lead program, losmapimod, is currently being investigated in clinical trials for the treatment of facioscapulohumeral muscular dystrophy (FSHD).

Notable affiliated individuals include key scientists and industry leaders who have contributed to the company's innovative approach to gene regulation. Fulcrum has attracted significant investment from prominent venture capital firms specializing in biotech. The company has achieved critical milestones in advancing its clinical trials and has made a substantial impact on the healthcare sector by addressing previously untreatable genetic conditions.

Fulcrum Therapeutics - Similar Companies

Fulcrum Pharmaceuticals logo

Fulcrum Pharmaceuticals

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

CAMP4 Therapeutics logo

CAMP4 Therapeutics

camp4tx.com

Triplet Therapeutics logo

Triplet Therapeutics

triplettx.com

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Kyntra Bio logo

Kyntra Bio

fibrogen.com

Blueprint Medicines logo

Blueprint Medicines

Scholar Rock Holding logo

Scholar Rock Holding

scholarrock.com

ProFound Therapeutics logo

ProFound Therapeutics

profoundtx.com

Flare Therapeutics logo

Flare Therapeutics

flaretx.com

Applied Therapeutics logo

Applied Therapeutics

Denali Therapeutics logo

Denali Therapeutics

Rectify Pharmaceuticals logo

Rectify Pharmaceuticals

rectifypharma.com

Kymera Therapeutics logo

Kymera Therapeutics

kymeratx.com

Foghorn Therapeutics logo

Foghorn Therapeutics

foghorntx.com

Fulcrum Therapeutics - Quick Facts

Who are Fulcrum Therapeutics' competitors?

Companies similar to Fulcrum Therapeutics include Fulcrum Pharmaceuticals, Astria Therapeutics, CAMP4 Therapeutics and Triplet Therapeutics.

When was Fulcrum Therapeutics founded?

Fulcrum Therapeutics was founded in 2016.

Where is Fulcrum Therapeutics' headquarters located?

Fulcrum Therapeutics' headquarters is located in Cambridge, MA, US.

When was Fulcrum Therapeutics' last funding round?

Fulcrum Therapeutics' most recent funding round was for $125M (USD) in January 2023.

How much has Fulcrum Therapeutics raised to-date?

As of Jan 17, 2023, Fulcrum Therapeutics has raised a total of $603.3M (USD).

How many employees does Fulcrum Therapeutics have?

Fulcrum Therapeutics has 89 employees as of Feb 6, 2024.

Fulcrum Therapeutics - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Healthtech
Unique IDs
  • ein: 474839948
  • secCik: 0001680581
  • ticker: FULC
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research